Risk‐adapted use of intravesical chemotherapy

Abstract

BJU InternationalVolume 102, Issue 9b p. 1247-1253 Risk-adapted use of intravesical chemotherapy Seth P. Lerner, Seth P. Lerner Scott Department of Urology, Baylor College of Medicine, Houston, TX, and Ohio State University, Columbus, OH, USASearch for more papers by this authorJessie L.-S. Au, Jessie L.-S. Au Scott Department of Urology, Baylor College of Medicine, Houston, TX, and Ohio State University, Columbus, OH, USASearch for more papers by this author Seth P. Lerner, Seth P. Lerner Scott Department of Urology, Baylor College of Medicine, Houston, TX, and Ohio State University, Columbus, OH, USASearch for more papers by this authorJessie L.-S. Au, Jessie L.-S. Au Scott Department of Urology, Baylor College of Medicine, Houston, TX, and Ohio State University, Columbus, OH, USASearch for more papers by this author First published: 15 October 2008 https://doi.org/10.1111/j.1464-410X.2008.07967.xCitations: 6 Seth P. Lerner, Professor, Beth and Dave Swalm Chair in Urologic Oncology, Scott Department of Urology, 6560 Fannin Suite 2100, Houston, TX 77030, USA. e-mail: slerner@bcm.tmc.edu Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume102, Issue9bSpecial Issue: Bladder CancerNovember 2008Pages 1247-1253 RelatedInformation